Point-Of-Care Glucose Testing Market To Reach $5.7 Billion By 2033

Point-of-Care Glucose Testing Market Growth & Trends

The global point-of-care glucose testing market size is estimated to reach USD 5.7 billion by 2033, expanding at a CAGR of 4.7% from 2026 to 2033, according to a new report by Grand View Research, Inc. An increase in the demand for Point-of-Care Testing (POCT) has been witnessed in recent years. As compared to the conventional laboratory testing performed in central lab settings, glucose POCT aids in performing effective diagnosis at the patient’s bedside. The easy and convenient operation of POCT has largely favored the growing usage of glucose meters across medical settings. The demand for performing bedside monitoring of blood sugar levels efficiently in a capillary blood sample and the need to ensure better management of carbohydrate metabolism have propelled the companies to launch innovative glucose meters in the market.

Various companies are investing in the development of needle-less devices to offer painless management of diabetes. For instance, GlucoTrack, a product manufactured by Integrity Applications (Israel), performs quantification using electromagnetic, ultrasonic, and thermal waves in combination. Eversense, painless glucose monitoring subcutaneous implant by Senseonics, quantifies glucose levels in interstitial fluid when placed beneath the skin. This is followed by data transmission to show the results in real-time. The latest no-code monitoring systems help in minimizing the errors that occur due to incorrect entry of strip codes. Whereas, others are incorporating noble metals, such as silver, gold, and platinum, which effectively reduce the electrical noise further improving accuracy.

 Request a free sample copy or view report summary: Point-of-Care Glucose Testing Market Report

Point-of-Care Glucose Testing Market Report Highlights

• The professional POC testing segment dominated the market in 2025 and accounted for the 51.9% of the overall revenue. The growth is supported by the widespread use of rapid blood glucose testing across hospitals, clinics, physician offices, emergency departments, and other healthcare settings.

• The institutional channels segment held the largest revenue share in 2025. The growth is supported by the established use of point-of-care glucose testing across hospitals, clinics, physician offices, nursing facilities, and other healthcare institutions.

• North America point-of-care glucose testing market is domimated the global market with revenue share of 40.2% in 2025. The growth is supported by the region's high diabetes burden, strong healthcare infrastructure, and widespread use of rapid glucose testing across hospitals, physician offices, emergency departments, and other care settings.

Point-of-Care Glucose Testing Market Segmentation

Grand View Research has segmented the global point-of-care glucose testing market on the basis of product, end use, and region:

Point-Of-Care Glucose Testing Product Outlook (Revenue, USD Million, 2021 - 2033)

• Professional POC Testing

  • Handheld Glucose Meters

  • Benchtop/Desktop Glucose Analyzers

  • Multiparameter POC Analyzers

  • Test Strips

  • Cartridges

  • Reagents & Controls

  • Lancets & Other Consumables

• Home-use/Self Testing

  • Blood Glucose Meters

  • Test Strips

  • Lancets & Lancing Devices

  • Other Accessories & Consumables

Point-Of-Care Glucose Testing End Use Outlook (Revenue, USD Million, 2021 - 2033)

• Institutional Channels

  • Hospitals and Clinics

  • Outpatient Facilities/Ambulatory Centers

  • Long-term Care Facilities

• Home-care Settings

Point-Of-Care Glucose Testing Region Outlook (Revenue, USD Million, 2021 - 2033)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Norway

  • Denmark

  • Sweden

• Asia Pacific

  • China

  • Japan

  • South Korea

  • Thailand

  • Australia

  • India

• Latin America

  • Brazil

  • Argentina

• MEA

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players of Point-Of-Care Glucose Testing Market

• F. Hoffmann-La Roche Ltd.

• Abbott

• Nova Biomedical

• LifeScan IP Holdings, LLC

• Ascensia Diabetes Care Holdings AG

• Trividia Health, Inc.

• EKF Diagnostics Holdings plc

• ARKRAY, Inc.

• A. Menarini Diagnostics S.r.l.

• AgaMatrix, Inc.